ArticleOncotarget2016

IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.

Yacine Merrouche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.